BioPharmGuy logo
Sponsored By:
Project Management Now
Purchase the BioPharmGuy data
Trianni
Talent Biotechs is defunct.

Fate: Bought by Kalytera Therapeutics, Mar 2017, $10M + $20M milestones


------------------
If you believe any of this information is incorrect, please let us know.